Standalone vs. Combo Ultrasound Units: Which Do You Need?
Discover why a dedicated ultrasound unit might outperform an all-in-one combo device for your specific diagnostic needs.
Choose a standalone ultrasound unit when you already own dedicated electrotherapy equipment, need a portable single-modality device, or work a narrow caseload where stimulation plays little role. For most practices building from scratch, a combination system delivers broader clinical utility at lower combined cost than purchasing ultrasound and electrotherapy separately.
- 1 MHz vs. 3 MHz depth: Frequency determines how deep the energy reaches: 1 MHz treats tissue 2 to 5 centimeters down, while 3 MHz stays in the top 1 to 2 centimeters for superficial structures.
- If your clinic already has dedicated electrotherapy hardware, a standalone ultrasound unit complements it cleanly rather than duplicating channels you will never use.
- Setting up a treatment room from nothing, a combination system almost always delivers better value per dollar and per square foot than buying the modalities separately.
- Ultrasound applied before electrical stimulation can lower tissue impedance and improve electrode coupling, so sequencing these modalities in one session has a real physiological basis.
- Battery operation for travel: If you work sidelines, home health visits, or satellite clinics, a unit with a built-in rechargeable battery is the difference between a system that travels and one that stays on a cart.
Where to start

Richmar TheraTouch CX4 4-Channel Electrotherapy & Ultrasound Combination System

Vectra Genisys 4-Channel Electrotherapy & Ultrasound Combination System with Cart
What Actually Separates a Standalone Ultrasound Unit from a Combo System
The distinction sounds obvious until you look at how clinics actually use these devices. A standalone ultrasound unit delivers therapeutic ultrasound and nothing else. A combination system pairs ultrasound with one or more electrotherapy modalities, typically interferential current, TENS, NMES, Russian stimulation, or high-volt galvanic, through a single housing and often a shared applicator workflow. Both categories treat soft tissue, both operate at 1 MHz and 3 MHz, and both appear in the same treatment rooms. The decision between them is less about capability and more about how your caseload is structured and what your budget can sustain over time.
In practice, the majority of professional therapeutic ultrasound equipment sold today is a combo system. That reflects how most clinicians actually work: ultrasound for tissue heating and phonophoresis, followed immediately by electrical stimulation for pain modulation or muscle re-education. Building both into one device reduces setup time, eliminates cable management across two carts, and spreads the capital cost across more billable procedures. It also reflects what manufacturers have prioritized. If you browse the therapeutic ultrasound machines in this category, you will find the standalone options are genuinely a minority.
That does not make standalone units obsolete. There are specific clinical situations where a dedicated ultrasound device is the right call, and understanding those situations is the only way to make the purchase decision correctly.
The Mechanism Behind Therapeutic Ultrasound

Therapeutic ultrasound converts electrical energy into mechanical energy through a piezoelectric crystal in the applicator head. That mechanical energy propagates through tissue as pressure waves at frequencies between 1 and 3 MHz. At 1 MHz, the waves penetrate to depths of roughly 2 to 5 centimeters, making it appropriate for larger muscle bellies and deeper joints. At 3 MHz, absorption is faster and shallower, roughly 1 to 2 centimeters, which suits superficial tendons, periarticular tissue, and small joints.
The thermal effects are well documented. Sustained temperature elevation in collagen-rich tissue increases extensibility, reduces viscosity, and enhances blood flow. Research on therapeutic heating of tendons and joint capsules consistently shows improved range of motion when ultrasound is applied before stretching or mobilization. Non-thermal effects operate through acoustic cavitation and acoustic streaming, mechanisms that influence membrane permeability, cellular metabolism, and inflammatory mediator activity, particularly at lower intensity pulsed settings. Pulsed mode at a 20% duty cycle, for example, produces minimal net heating while still generating these mechanical effects.
The Richmar TheraTouch UX2 captures this well in its design: it offers pulsed and continuous modes across both 1 MHz and 3 MHz, with intensity readable in either W or W/cm2, and a BNR ratio of 5:1. That BNR figure matters because a lower beam non-uniformity ratio means more even energy distribution across the treatment field, reducing the risk of hotspot formation and allowing clinicians to move at a steadier pace. Those are not cosmetic differences between devices; they affect both safety and treatment outcome.
When a Dedicated Ultrasound Unit Actually Makes Sense

The honest answer is that standalone units serve a narrower set of clinical needs than combo systems, but for those needs they are often the better solution rather than a compromise. Three scenarios come up repeatedly in practice.
You Already Have Electrotherapy Covered
Clinics that invested in dedicated multi-channel electrotherapy units before adding ultrasound to their offerings do not need to replicate that capability in a second device. Buying a combo system in this situation means paying for electrotherapy channels you will never use clinically, because your existing setup already handles that workflow. A standalone ultrasound unit slots in cleanly as a complement, not a replacement.
You Need a Portable Treatment Option
Standalone ultrasound units tend to be lighter and more compact than their combo counterparts, partly because the electronics are simpler and partly because manufacturers targeting this segment design for portability. The Richmar TheraTouch UX2, for instance, is described as light enough for tabletop or therapy cart use, with a dual-holster design that accommodates both the included 1 cm2 and 5 cm2 applicators without a dedicated cart. For outreach programs, home visit protocols, or satellite clinic setups where space is tight, that matters more than modality breadth.
Your Treatment Focus is Narrowly Defined
Sports medicine practitioners dealing almost exclusively with tendinopathy, muscle tears, and post-surgical scar tissue mobilization may find that ultrasound covers 90% of their device-assisted treatment time. Electrotherapy does not figure heavily into every scope of practice, and a standalone unit removes the cognitive overhead of a device with modalities you do not use. There is something to be said for a simpler interface when treatment time is short and patient turnover is high.
The Case for Combination Systems in Most Clinical Settings

For most practices setting up from scratch or upgrading a treatment room, a combination electrotherapy and ultrasound system is the more defensible purchase. The financial logic is direct: a single combo unit costs less than buying ultrasound and electrotherapy separately, occupies one cart position, and generates revenue across two billing categories. The clinical logic follows the same line, since ultrasound and electrical stimulation are frequently sequenced in the same treatment session anyway.
The Richmar TheraTouch CX2 is a clear example of how much capability a mid-range combo system can compress into one device. Its two independent stimulation channels support interferential, premodulated, biphasic in symmetrical, asymmetrical, and RAAS configurations, NMS, Russian, high-volt, and microcurrent waveforms. The ultrasound section delivers both 1 MHz and 3 MHz with pulsed and continuous output, and the stim output channel allows simultaneous ultrasound and stimulation delivery. Eight evidence-based clinical protocols with electrode placement suggestions are built in, and users can save up to 99 custom protocols. At $2,599.95, that is a broad clinical toolkit for the price.
Step up to the four-channel Richmar TheraTouch CX4 at $3,199.95 and the multi-patient functionality becomes a genuine operational advantage. Four independent stimulation channels with a multi-patient mode allow one practitioner to run concurrent treatments, which compresses schedule density in a meaningful way. For a busy outpatient orthopedic or sports medicine clinic, the capacity to have two or three patients in active treatment simultaneously changes how the day runs.
The Vectra Genisys system takes the modular concept further, consolidating up to six therapeutic modalities including ultrasound, electrotherapy, combination ultrasound and electrotherapy, laser, sEMG, and sEMG with stimulation into a single platform. Its Electronic Signature technology means any applicator plugged into the unit is automatically recognized, and all ultrasound and laser applicators are interchangeable. The system ships with a 5 cm2 ultrasound applicator, and the applicator heads include a warming feature for patient comfort and are waterproof for underwater treatments. At $6,900.28, it is a significant capital investment, but the modular architecture means the system can expand as clinical needs change, rather than requiring full replacement.
Comparing the Key Models Side by Side
The table below covers the primary units available in this category. Combo systems dominate the list, which reflects the reality of the market rather than an editorial preference. The standalone options included here represent the clearest decision points for buyers who have already considered both directions.
| Model | Type | Channels | Ultrasound Frequencies | Price |
|---|---|---|---|---|
Richmar SoundCare Plus Professional Therapeutic Ultrasound System with 1 cm and 5 cm Applicators |
Standalone ultrasound | Not published | Not published | $849.95 |
Richmar TheraTouch CX2 2-Channel Electrotherapy & Ultrasound Combination System |
Combo | 2 | 1 MHz, 3 MHz | $2,599.95 |
Chattanooga Intelect Transport 2 Therapeutic Ultrasound System |
Standalone ultrasound | N/A | 1 MHz, 3.3 MHz | $2,160.38 |
Chattanooga Intelect Transport 2 Electrotherapy & Ultrasound Combination System |
Combo | Not published | 1 MHz, 3.3 MHz | $4,173.48 |
Chattanooga Intelect Legend 2 2-Channel Electrotherapy & Ultrasound Combination System |
Combo | 2 | Not published | $5,108.35 |
Chattanooga Intelect Legend 2 4-Channel Electrotherapy & Ultrasound Combination System |
Combo | 4 | Not published | $5,976.42 |
A few things stand out from this layout. First, the price gap between a standalone ultrasound unit and an entry-level combo system is not always as large as practitioners expect. The Chattanooga Intelect Transport 2 standalone ultrasound comes in at $2,160.38, while its combo counterpart is $4,173.48, a difference that is real but needs to be evaluated against what that electrotherapy capability is worth to the practice. Second, the Richmar SoundCare Plus at $849.95 sits in a different tier entirely, accessible for practices that genuinely only need ultrasound and do not want to over-invest. Third, the upper range of the combo category, represented by the Chattanooga Intelect Legend 2 systems, reflects the cost of build quality and clinical breadth rather than feature bloat.
Applicator Size, Frequency Selection, and Treatment Area

One of the practical details that gets underweighted in purchasing decisions is applicator selection, both in terms of which heads ship with the unit and how the system handles them. The Chattanooga Intelect Transport 2 ultrasound system ships with applicator transmitters in 2 cm2, 5 cm2, and 10 cm2 sizes, each with an LED coupling light, connected via a quick-connect magnetic cart attachment that requires no tools. That kind of thoughtful hardware design reduces setup time and the risk of connector damage from repeated plugging and unplugging under clinical pressure.
The 10 cm2 applicator is worth noting specifically. It is less commonly included in entry-level systems and meaningfully changes treatment efficiency on large muscle groups like the quadriceps, paraspinals, or hamstrings. Covering more surface area per pass reduces total treatment time and allows the clinician to maintain better contact pressure without rushing. For practices treating a high volume of larger athletes or post-surgical patients with broad treatment zones, the availability of a 10 cm2 head is a legitimate differentiator.
At the other end of the size spectrum, the 1 cm2 applicator is essential for periarticular work around small joints, the carpal tunnel region, the lateral epicondyle, and other anatomically confined areas. Systems that include both ends of the applicator size range out of the box offer more clinical flexibility without requiring additional accessory purchases. The Richmar TheraTouch UX2 includes both 1 cm2 and 5 cm2 heads in its dual-holster design, which keeps both accessible at the device rather than requiring retrieval from storage.
Built-In Protocols and Clinical Workflow
The quality of a unit's interface and protocol library has a larger effect on daily clinical workflow than manufacturers typically acknowledge in their marketing. Evidence-based preset protocols, the kind that guide a clinician through frequency, intensity, duty cycle, and treatment time for a specific indication, reduce cognitive load in a busy treatment room and help newer clinicians apply parameters consistently. The Richmar TheraTouch CX2, for example, includes eight stimulation protocols with electrode placement guidance and accommodates up to 99 user-saved custom protocols. Its bilingual interface in English and Spanish is also worth noting for clinics serving diverse patient populations.
The Richmar TheraTouch UX2 takes a similar approach on the ultrasound-only side, grouping clinical protocols intuitively on a color LCD touchscreen and guiding clinicians step by step through parameter selection. The "favorites" feature lets users store frequently used protocol combinations for future retrieval, which matters in high-volume settings where repeating setup from scratch for common presentations wastes measurable time. The question of whether a device makes the clinician faster or slower in the first three minutes of a treatment session is not trivial.
Devices without structured protocol guidance are not inherently inferior, but they demand more from the operator. A highly experienced clinician who prefers manual parameter entry may find preset protocols restrictive. A practice with variable staff experience, or one that supervises students or aides, benefits from the consistency that protocol-driven interfaces provide. Matching the interface complexity to the clinical team's experience profile is a real consideration that rarely appears in equipment reviews.
How Much Does Adding Electrotherapy Actually Change Things

The question of whether ultrasound therapy and electrotherapy genuinely belong together is worth examining rather than assuming. Research on the combination of these modalities is reasonably well established for specific conditions. Ultrasound used before electrical stimulation, for example, can improve electrode-to-tissue coupling and reduce impedance, which may enhance the effectiveness of subsequent stimulation. Simultaneous phonophoresis and stimulation has been studied for drug delivery combined with pain modulation. The clinical case for pairing these modalities in the same treatment session is not just a matter of convenience; there is a physiological rationale behind it.
That said, the rationale only matters if your patient population is one where both modalities are clinically indicated together. Practitioners focused on phonophoresis, scar tissue remodeling, or pre-exercise tissue preparation may rarely reach for a stimulation channel during an ultrasound session. In that scenario, the combo system's additional capability is a feature you are paying for and not using. The decision of whether both modalities belong in your toolkit comes down to caseload composition, not equipment category.
The practical middle ground that many practices land on is a combo system as the primary device, with a standalone ultrasound unit serving as a backup or overflow treatment station. This configuration gives the clinic redundancy in ultrasound capability without duplicating the more expensive electrotherapy hardware. It is a reasonable allocation when the ultrasound schedule is consistently full and adding a second treatment bay is constrained by space rather than budget.
Portability and Battery-Powered Operation
One feature category that distinguishes certain units and matters considerably for specific practice types is built-in battery operation. The Chattanooga Intelect Transport 2, in both its standalone and combo configurations, is designed with a built-in rechargeable battery pack that allows it to function away from a wall outlet. That design detail is the difference between a system that travels and a system that stays on a cart. For athletic trainers working sideline coverage, occupational therapists doing home health visits, or any practitioner running satellite clinics without consistent outlet access, battery operation is not a luxury.
The Transport 2 line is specifically marketed as ergonomically designed for tabletop, cart, or mobile use, with the battery pack architecture integrated rather than bolted on. The included quick-connect magnetic transmitter attachment removes the cable discipline problem that makes other portable systems clumsy in field settings. These are considered design details when you are reading a spec sheet, but they represent real friction reduction in actual use. The adjacent category of biofeedback and sEMG equipment has seen the same portability-first design trend, and clinical expectations for equipment mobility have shifted accordingly.
Mains-powered units, by contrast, typically offer more consistent power output and are not subject to battery degradation over time. For fixed clinic installations where outlet access is not a constraint, the added weight and cost of battery systems are unnecessary. Most standalone and combo units in the mid-to-upper price range are mains-powered and cart-mounted by design. The Richmar TheraTouch units, for instance, reference cart compatibility without specifying battery capability, suggesting they are intended for fixed-position clinical use.
How to Make the Call for Your Practice
The practical framework for this decision has a few clear branches. Start with your current equipment inventory. If you have functional electrotherapy hardware, a standalone ultrasound unit fills the gap cleanly and avoids redundant spend. If you are starting from scratch in a treatment room, a combo system almost always represents better value per square foot and per dollar invested.
Then consider patient volume and session structure. A single-clinician practice with straightforward patient flow may find a two-channel combo system more than sufficient. A multi-practitioner clinic with overlapping schedules and diverse caseloads should look seriously at four-channel systems with multi-patient capability, or consider whether a modular platform like the Vectra Genisys offers a better long-term architecture for expanding treatment services without buying new hardware each time.
Budget framing matters too, but not in the way it usually gets discussed. The relevant number is not just the purchase price; it is the cost per billable procedure over the equipment's useful life. A higher-priced combo system that generates revenue across ultrasound, electrical stimulation, and potentially laser or sEMG procedures amortizes its cost faster than a standalone unit used for one billing category. That arithmetic changes if your payer mix does not reimburse well for one of those modalities, which is a practice-specific variable that no general article can resolve for you.
Finally, think about your staff. A complex multi-modality platform with an unfamiliar interface can sit underutilized if the clinical team does not have time to get comfortable with it. A well-designed standalone unit with a clear, intuitive interface and relevant preset protocols can be up and running productively within a short orientation period. Equipment that gets used correctly produces better clinical outcomes and better return on investment than equipment that gets used at 40% of its capability because it is confusing to operate. The best device for your practice is not always the most feature-rich one; it is the one your team will actually use well. You will find both standalone and combination options across the full therapeutic ultrasound machines collection, organized by type and price range to make that comparison easier.
More therapeutic ultrasound machines worth a look

Richmar TheraTouch CX2 2-Channel Electrotherapy & Ultrasound Combination System

Richmar TheraTouch UX2 Advanced Therapeutic Ultrasound System
Frequently asked questions
Is a standalone ultrasound unit suitable for a small clinic just starting out?▾
It depends on what other equipment you already own. If you are starting from zero, a combination system is usually the smarter first purchase because it covers ultrasound and electrotherapy in one device at a lower combined cost. A standalone unit makes more sense when you already have a capable electrotherapy setup and just need to add ultrasound without duplicating what you have.
Are there any safety differences between standalone and combo ultrasound units?▾
The core safety considerations are the same across both types: BNR ratio, output calibration, and mode selection. A lower beam non-uniformity ratio means more even energy distribution and less risk of hotspot formation. The Richmar TheraTouch UX2, for example, carries a BNR of 5:1, which is the same figure listed for the Richmar TheraTouch CX2 combo system, so safety performance at that level is not a reason to choose one type over the other.
How much does a standalone ultrasound unit cost compared to a combo system?▾
The Richmar TheraTouch UX2, a dedicated standalone ultrasound unit, is priced at $2,395.95. Entry-level combo systems start higher: the Richmar TheraTouch CX2 two-channel combination unit is $2,599.95, and the four-channel CX4 is $3,199.95. At the upper end, a modular system like the Vectra Genisys with cart reaches $6,900.28. The gap between a standalone and a mid-range combo is relatively modest, which is why the combo is often the better value for a practice that needs both modalities.
How difficult is it to set up and learn a standalone ultrasound unit?▾
Standalone units are generally simpler to learn than combo systems because there are fewer modalities, menus, and parameter combinations to navigate. The Richmar TheraTouch UX2 uses a color LCD touchscreen with clinical protocols that guide clinicians step by step, and a favorites feature lets you save frequently used settings. For high-turnover treatment environments, that reduced cognitive load can be a real practical advantage.
What are the ongoing costs of running a therapeutic ultrasound unit?▾
The main recurring costs are ultrasound coupling gel, applicator maintenance, and eventual transducer servicing if the crystal degrades over time. Some systems use proprietary applicator heads, so it is worth checking replacement pricing before you buy. Combo systems add the cost of electrodes and lead wires, which are consumables that need regular replacement depending on patient volume. A standalone unit has a narrower consumable footprint, which can add up to modest savings over several years of heavy use.
How often does a therapeutic ultrasound unit need maintenance?▾
Routine maintenance mostly involves keeping applicator heads clean, checking cable integrity, and periodically verifying output calibration. Manufacturers generally recommend annual calibration checks to confirm the device is delivering the programmed intensity accurately, since an uncalibrated unit can under- or over-treat without any visible indication. The Vectra Genisys handles applicator recognition automatically through its Electronic Signature system, which reduces one potential source of setup error, though it does not eliminate the need for periodic calibration.
How do I choose the right frequency and applicator size for my patients?▾
Frequency and applicator size are determined by tissue depth and treatment area. At 1 MHz, energy penetrates roughly 2 to 5 centimeters, making it appropriate for large muscle bellies and deeper joints. At 3 MHz, penetration is shallower at roughly 1 to 2 centimeters, which suits superficial tendons and small joints. Applicator size follows treatment area: a 5 cm2 head covers larger surfaces efficiently, while a 1 cm2 head is better for small or irregular areas. The Richmar TheraTouch UX2 includes both sizes, which is useful if your caseload is varied.
What is the most common mistake clinicians make when choosing between standalone and combo units?▾
The most common mistake is buying a combo system purely out of habit or assumption, without checking whether electrotherapy is actually part of the intended workflow. Clinics with a narrow treatment focus, or those that already own capable electrotherapy equipment, sometimes end up with modalities they never use and a more complex interface than the job requires. The reverse also happens: practitioners buy a standalone unit to save money upfront, then find themselves needing electrotherapy capability within a year and spending more in total than a combo system would have cost.
Shop therapeutic ultrasound machines
Quality inspected before shipping, with expert US-based phone support before and after purchase.




